Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition.
Partridge, J.R., Choy, R.M., Silva-Garcia, A., Yu, C., Li, Z., Sham, H., Metcalf, B.(2019) J Struct Biol 206: 170-182
- PubMed: 30876891 
- DOI: 10.1016/j.jsb.2019.03.001
- Primary Citation of Related Structures:  
6O1S, 6O1G, 6BFP - PubMed Abstract: 
Plasma kallikrein (pKal) is a serine protease responsible for cleaving high-molecular-weight kininogen to produce the pro-inflammatory peptide, bradykinin. Unregulated pKal activity can lead to hereditary angioedema (HAE) following excess bradykinin rele ...